Table 1.

Logistic regression results for use of glucagon-like peptide-1 receptor agonists.

	Estimate	SE	P value	Odds ratio (95% CI)
Intercept	–3.89	0.57	<.001	N/Aa
Total patients with type 2 diabetes	0.005	0.003	.06	1.01 (1.000-1.010)
Intervention	1.50	0.58	.001	4.49 (1.445-13.969)
Glucagon-like peptide-1 receptor agonist use in the preintervention period	5.42	0.65	<.001	225.53 (62.928-808.282)
Endocrinologist	1.09	1.005	.28	2.98 (0.416-21.384)

^aN/A: not applicable.